Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus.
Identifieur interne : 002460 ( PubMed/Corpus ); précédent : 002459; suivant : 002461Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus.
Auteurs : Masanobu Yamate ; Makiko Yamashita ; Toshiyuki Goto ; Shoutaro Tsuji ; Yong-Gang Li ; Jiranan Warachit ; Mikihiro Yunoki ; Kazuyoshi IkutaSource :
- Microbes and infection [ 1286-4579 ] ; 2005.
English descriptors
- KwdEn :
- Animals, Antigens, Surface (analysis), Blotting, Western, Carboxypeptidases (analysis), Chlorocebus aethiops, Cytopathogenic Effect, Viral, Down-Regulation, Flow Cytometry, Membrane Glycoproteins (analysis), Microscopy, Confocal, Microscopy, Electron, Microscopy, Fluorescence, Nucleocapsid Proteins (analysis), Peptidyl-Dipeptidase A, RNA, Viral (analysis), SARS Virus (growth & development), Spike Glycoprotein, Coronavirus, Vero Cells (virology), Viral Envelope Proteins (analysis).
- MESH :
- chemical , analysis : Antigens, Surface, Carboxypeptidases, Membrane Glycoproteins, Nucleocapsid Proteins, RNA, Viral, Viral Envelope Proteins.
- growth & development : SARS Virus.
- virology : Vero Cells.
- Animals, Blotting, Western, Chlorocebus aethiops, Cytopathogenic Effect, Viral, Down-Regulation, Flow Cytometry, Microscopy, Confocal, Microscopy, Electron, Microscopy, Fluorescence, Peptidyl-Dipeptidase A, Spike Glycoprotein, Coronavirus.
Abstract
Little information is available on persistent infection of severe acute respiratory syndrome (SARS) coronavirus (CoV). In this study, we established persistent infection of SARS-CoV in the Vero E6 cell line. Acute infection of Vero E6 with SARS-CoV produced a lytic infection with characteristic rounding cytopathic effects (CPE) and the production of a large number of infectious particles in the culture fluid within 3 days post-infection. Upon subsequent culturing of the remaining adherent cells, the cells gradually proliferated and recovered normal morphology similar to that of the parental cells, and continued to produce large numbers of infectious viral particles during the observation period of 5 months. Among a total of 87 cell clones obtained from the persistently infected Vero E6, only four cell clones (named #13, #18, #21, and #34) were positive for viral RNA. Clones #13, #18, and #34 shifted to viral RNA-negative during subsequent cultures, while #21 continuously produced infectious particles at a high rate. The SARS-CoV receptor, angiotensin-converting enzyme 2, was almost completely down regulated from the cell surface of persistently infected cells. Western blot analysis as well as electron microscopy indicated that the ratios of spike to nucleocapsid protein in clone #21 as well as its parental persistently infected cells were lower than that in the cells in the acute phase of infection. These Vero E6 cells persistently infected with SARS-CoV may be useful for clarifying the mechanism of the persistent infection and also for elucidating the possible pathophysiologic significance of such long-term maintenance of this virus.
DOI: 10.1016/j.micinf.2005.05.013
PubMed: 16269264
Links to Exploration step
pubmed:16269264Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus.</title>
<author><name sortKey="Yamate, Masanobu" sort="Yamate, Masanobu" uniqKey="Yamate M" first="Masanobu" last="Yamate">Masanobu Yamate</name>
<affiliation><nlm:affiliation>Department of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yamashita, Makiko" sort="Yamashita, Makiko" uniqKey="Yamashita M" first="Makiko" last="Yamashita">Makiko Yamashita</name>
</author>
<author><name sortKey="Goto, Toshiyuki" sort="Goto, Toshiyuki" uniqKey="Goto T" first="Toshiyuki" last="Goto">Toshiyuki Goto</name>
</author>
<author><name sortKey="Tsuji, Shoutaro" sort="Tsuji, Shoutaro" uniqKey="Tsuji S" first="Shoutaro" last="Tsuji">Shoutaro Tsuji</name>
</author>
<author><name sortKey="Li, Yong Gang" sort="Li, Yong Gang" uniqKey="Li Y" first="Yong-Gang" last="Li">Yong-Gang Li</name>
</author>
<author><name sortKey="Warachit, Jiranan" sort="Warachit, Jiranan" uniqKey="Warachit J" first="Jiranan" last="Warachit">Jiranan Warachit</name>
</author>
<author><name sortKey="Yunoki, Mikihiro" sort="Yunoki, Mikihiro" uniqKey="Yunoki M" first="Mikihiro" last="Yunoki">Mikihiro Yunoki</name>
</author>
<author><name sortKey="Ikuta, Kazuyoshi" sort="Ikuta, Kazuyoshi" uniqKey="Ikuta K" first="Kazuyoshi" last="Ikuta">Kazuyoshi Ikuta</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16269264</idno>
<idno type="pmid">16269264</idno>
<idno type="doi">10.1016/j.micinf.2005.05.013</idno>
<idno type="wicri:Area/PubMed/Corpus">002460</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002460</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus.</title>
<author><name sortKey="Yamate, Masanobu" sort="Yamate, Masanobu" uniqKey="Yamate M" first="Masanobu" last="Yamate">Masanobu Yamate</name>
<affiliation><nlm:affiliation>Department of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yamashita, Makiko" sort="Yamashita, Makiko" uniqKey="Yamashita M" first="Makiko" last="Yamashita">Makiko Yamashita</name>
</author>
<author><name sortKey="Goto, Toshiyuki" sort="Goto, Toshiyuki" uniqKey="Goto T" first="Toshiyuki" last="Goto">Toshiyuki Goto</name>
</author>
<author><name sortKey="Tsuji, Shoutaro" sort="Tsuji, Shoutaro" uniqKey="Tsuji S" first="Shoutaro" last="Tsuji">Shoutaro Tsuji</name>
</author>
<author><name sortKey="Li, Yong Gang" sort="Li, Yong Gang" uniqKey="Li Y" first="Yong-Gang" last="Li">Yong-Gang Li</name>
</author>
<author><name sortKey="Warachit, Jiranan" sort="Warachit, Jiranan" uniqKey="Warachit J" first="Jiranan" last="Warachit">Jiranan Warachit</name>
</author>
<author><name sortKey="Yunoki, Mikihiro" sort="Yunoki, Mikihiro" uniqKey="Yunoki M" first="Mikihiro" last="Yunoki">Mikihiro Yunoki</name>
</author>
<author><name sortKey="Ikuta, Kazuyoshi" sort="Ikuta, Kazuyoshi" uniqKey="Ikuta K" first="Kazuyoshi" last="Ikuta">Kazuyoshi Ikuta</name>
</author>
</analytic>
<series><title level="j">Microbes and infection</title>
<idno type="ISSN">1286-4579</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antigens, Surface (analysis)</term>
<term>Blotting, Western</term>
<term>Carboxypeptidases (analysis)</term>
<term>Chlorocebus aethiops</term>
<term>Cytopathogenic Effect, Viral</term>
<term>Down-Regulation</term>
<term>Flow Cytometry</term>
<term>Membrane Glycoproteins (analysis)</term>
<term>Microscopy, Confocal</term>
<term>Microscopy, Electron</term>
<term>Microscopy, Fluorescence</term>
<term>Nucleocapsid Proteins (analysis)</term>
<term>Peptidyl-Dipeptidase A</term>
<term>RNA, Viral (analysis)</term>
<term>SARS Virus (growth & development)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Vero Cells (virology)</term>
<term>Viral Envelope Proteins (analysis)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antigens, Surface</term>
<term>Carboxypeptidases</term>
<term>Membrane Glycoproteins</term>
<term>Nucleocapsid Proteins</term>
<term>RNA, Viral</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Blotting, Western</term>
<term>Chlorocebus aethiops</term>
<term>Cytopathogenic Effect, Viral</term>
<term>Down-Regulation</term>
<term>Flow Cytometry</term>
<term>Microscopy, Confocal</term>
<term>Microscopy, Electron</term>
<term>Microscopy, Fluorescence</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Little information is available on persistent infection of severe acute respiratory syndrome (SARS) coronavirus (CoV). In this study, we established persistent infection of SARS-CoV in the Vero E6 cell line. Acute infection of Vero E6 with SARS-CoV produced a lytic infection with characteristic rounding cytopathic effects (CPE) and the production of a large number of infectious particles in the culture fluid within 3 days post-infection. Upon subsequent culturing of the remaining adherent cells, the cells gradually proliferated and recovered normal morphology similar to that of the parental cells, and continued to produce large numbers of infectious viral particles during the observation period of 5 months. Among a total of 87 cell clones obtained from the persistently infected Vero E6, only four cell clones (named #13, #18, #21, and #34) were positive for viral RNA. Clones #13, #18, and #34 shifted to viral RNA-negative during subsequent cultures, while #21 continuously produced infectious particles at a high rate. The SARS-CoV receptor, angiotensin-converting enzyme 2, was almost completely down regulated from the cell surface of persistently infected cells. Western blot analysis as well as electron microscopy indicated that the ratios of spike to nucleocapsid protein in clone #21 as well as its parental persistently infected cells were lower than that in the cells in the acute phase of infection. These Vero E6 cells persistently infected with SARS-CoV may be useful for clarifying the mechanism of the persistent infection and also for elucidating the possible pathophysiologic significance of such long-term maintenance of this virus.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16269264</PMID>
<DateCompleted><Year>2006</Year>
<Month>03</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1286-4579</ISSN>
<JournalIssue CitedMedium="Print"><Volume>7</Volume>
<Issue>15</Issue>
<PubDate><Year>2005</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Microbes and infection</Title>
<ISOAbbreviation>Microbes Infect.</ISOAbbreviation>
</Journal>
<ArticleTitle>Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus.</ArticleTitle>
<Pagination><MedlinePgn>1530-40</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Little information is available on persistent infection of severe acute respiratory syndrome (SARS) coronavirus (CoV). In this study, we established persistent infection of SARS-CoV in the Vero E6 cell line. Acute infection of Vero E6 with SARS-CoV produced a lytic infection with characteristic rounding cytopathic effects (CPE) and the production of a large number of infectious particles in the culture fluid within 3 days post-infection. Upon subsequent culturing of the remaining adherent cells, the cells gradually proliferated and recovered normal morphology similar to that of the parental cells, and continued to produce large numbers of infectious viral particles during the observation period of 5 months. Among a total of 87 cell clones obtained from the persistently infected Vero E6, only four cell clones (named #13, #18, #21, and #34) were positive for viral RNA. Clones #13, #18, and #34 shifted to viral RNA-negative during subsequent cultures, while #21 continuously produced infectious particles at a high rate. The SARS-CoV receptor, angiotensin-converting enzyme 2, was almost completely down regulated from the cell surface of persistently infected cells. Western blot analysis as well as electron microscopy indicated that the ratios of spike to nucleocapsid protein in clone #21 as well as its parental persistently infected cells were lower than that in the cells in the acute phase of infection. These Vero E6 cells persistently infected with SARS-CoV may be useful for clarifying the mechanism of the persistent infection and also for elucidating the possible pathophysiologic significance of such long-term maintenance of this virus.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamate</LastName>
<ForeName>Masanobu</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yamashita</LastName>
<ForeName>Makiko</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Goto</LastName>
<ForeName>Toshiyuki</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tsuji</LastName>
<ForeName>Shoutaro</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Yong-Gang</ForeName>
<Initials>YG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Warachit</LastName>
<ForeName>Jiranan</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Yunoki</LastName>
<ForeName>Mikihiro</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ikuta</LastName>
<ForeName>Kazuyoshi</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2005</Year>
<Month>07</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Microbes Infect</MedlineTA>
<NlmUniqueID>100883508</NlmUniqueID>
<ISSNLinking>1286-4579</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000954">Antigens, Surface</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019590">Nucleocapsid Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.-</RegistryNumber>
<NameOfSubstance UI="D002268">Carboxypeptidases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.15.1</RegistryNumber>
<NameOfSubstance UI="D007703">Peptidyl-Dipeptidase A</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.17.-</RegistryNumber>
<NameOfSubstance UI="C413524">angiotensin converting enzyme 2</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000954" MajorTopicYN="N">Antigens, Surface</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002268" MajorTopicYN="N">Carboxypeptidases</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003588" MajorTopicYN="N">Cytopathogenic Effect, Viral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018613" MajorTopicYN="N">Microscopy, Confocal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008856" MajorTopicYN="N">Microscopy, Fluorescence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019590" MajorTopicYN="N">Nucleocapsid Proteins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007703" MajorTopicYN="N">Peptidyl-Dipeptidase A</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000254" MajorTopicYN="Y">growth & development</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year>
<Month>03</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2005</Year>
<Month>05</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2005</Year>
<Month>05</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>11</Month>
<Day>5</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>11</Month>
<Day>5</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">16269264</ArticleId>
<ArticleId IdType="pii">S1286-4579(05)00200-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.micinf.2005.05.013</ArticleId>
<ArticleId IdType="pmc">PMC7110502</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Virol. 1999 Apr;73(4):3338-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10074188</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 May 17;361(9370):1730-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12767752</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Jul 9;319(4):1228-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15194498</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1997 Apr;71(4):2959-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9060655</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Pathol. 2004 Jun;203(2):631-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15141377</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Neurology. 1982 Mar;32(3):292-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6278362</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1979 Oct 30;98(2):448-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">228481</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2004 Apr 1;189(7):1158-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15031782</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2003 Dec;84(Pt 12):3291-3303</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14645910</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1977-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12671062</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Jun;78(11):5642-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15140961</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12892955</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1999 Apr;73(4):3326-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10074187</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1997 Nov;71(11):8860-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9343248</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Adv Exp Med Biol. 1993;342:327-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7516107</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1948-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12748314</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Jun;78(11):5619-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15140959</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2004 Jul 15;190(2):379-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15216476</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2004 Sep;74(1):1-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15258961</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1978 Jul 15;88(2):325-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">211715</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 1980;6(3):259-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6262459</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Pathol. 2004 Jun;203(2):622-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15141376</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1989 Jun;170(2):408-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2499113</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lab Anim Sci. 1993 Feb;43(1):15-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8384676</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Chem. 2004 Jul;50(7):1237-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15229153</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Ann Neurol. 1992 May;31(5):525-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1596089</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2004 Jul;73(3):332-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15170625</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1996 Jun;70(6):3947-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8648732</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1994 Jan;198(1):355-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8259671</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2004 Jul;73(3):323-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15170624</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2003 Nov;71(3):323-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12966536</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1967 Dec;58(6):2268-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4298953</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Nov;72(11):9286-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9765476</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Microbiol Immunol. 2000;44(9):765-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11092240</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Microb Pathog. 1987 Aug;3(2):79-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2849019</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Gastroenterology. 2003 Oct;125(4):1011-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14517783</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1993 Aug;67(8):4504-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8392595</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1995 Jun 1;209(2):337-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7778268</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Jul 9;319(4):1216-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15194496</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 1985 Sep 6;229(4717):978-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2992091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11733-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8265618</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1990 Sep;64(9):4108-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2384915</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1984 Sep;137(2):347-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6091333</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1990 Apr;175(2):418-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2158180</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Pathol. 2004 Feb;202(2):157-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14743497</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Neuroscience. 2000;101(1):219-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11068150</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Pathol. 2004 Jul;203(3):740-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15221932</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1995 Sep;69(9):5535-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7636998</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002460 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002460 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:16269264 |texte= Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:16269264" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |